I hope we will also be able to persuade them to give a clearer picture of just how disabling even mild ME is, and what a wide range of difficult, disabling and unpleasant symptoms we contend with every day even when successfully staying within our energy envelope.
But we shouldn't have to. The difference between the MS guidelines and those for ME/CFS show that they are coming from two very different angles.
MS as a recognised serious incurable neurological illness regardless of severity and ME as this kind of nebulous, 'is it an illness or isn't it' which has so many falsly deeply embedded links to psychiatry that have become part of everything that defines it.
From the way it is classified with mild, moderate and severe, to the definitions of recovery, and the way 'improvement' is measured.
All that seems to be happening is that every time we try to define symptoms in an effort to
give a clearer picture of just how disabling even mild ME is, and what a wide range of difficult, disabling and unpleasant symptoms we contend with every day even when successfully staying within our energy envelope.
they appropriate the terms used and present their own explanation.
This has gone from the use of 'fatigue', to 'PEM' being equated to post-exertional fatigue, 'energy envelope' being used as a new term for 'baseline' to help patients increase activity (GET?) and so on.
In the TWIV discussion recently posted on another thread, David Tuller was trying to explain to his american colleagues about this grip that psychiatry has over ME in the UK and its implications for other chronic illnesses added to the MUS category.
I think this current rewrite of the guidelines should be viewed as 'round one'.
Getting PACE and similar largely excluded from the evidence was huge. But it is still all there available to access and influence, as are its proponents.
Given the current situation re 'long-covid' and the research being carried out and the whole issue of 'post-viral syndromes' being raised I would hope that a recommendation is made that once the new guidelines for ME/CFS are published that
a) all references across the NHS be changed to reflect the changes in the guidelines including the name.
b) all materials, including treatment and training courses also reflect the changes.
c) that ME/CFS be removed from MUS, be officially classified and included under neurology.
d) any new biomedical developments made within the research of 'long-covid' that may be applicable to ME/CFS be replicated with ME/CFS patients.
We have a long way to go.